Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China
Yuankai Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Lin Gui(University of Chicago), Shulian Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Jin(Chinese Academy of Medical Sciences & Peking Union Medical College), Liqiang Zhou(Nanchang University), Ying Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaohui He(Chinese Academy of Medical Sciences & Peking Union Medical College), Shengyu Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianliang Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yong-Wen Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Changgong Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yueping Liu(Hebei Medical University)
Cited by 126
Related Papers
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
|The Lancet Oncology|2016|1.2k
Aspect-based sentiment analysis via affective knowledge enhanced graph convolutional networks
|Knowledge-Based Systems|2021|518
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Tissue factor expression by endothelial cells in sickle cell anemia.
|Journal of Clinical Investigation|1998|224